Results 161 to 170 of about 315,177 (310)

Variability in venom composition of European viper subspecies limits the cross-effectiveness of antivenoms [PDF]

, 2018
Duregotti, Elisa, Giampreti, Andrea, Locatelli, Carlo Alessandro, Lonati, Davide, Pirazzini, Marco, Rossetto, Ornella, Zanetti, Giulia   +6 more
core   +1 more source

Anticoagulant Treatment [PDF]

BMJ, 1962
openaire   +2 more sources

Bioprospecting Ulleungdo‐isolated microalgae for carbon valorization and utilization

Biofuels, Bioproducts and Biorefining, EarlyView.
Abstract The growing demand for renewable energy alternatives has intensified global interest in microalgae as versatile bioresources for carbon valorization and bioenergy production. Owing to their rapid growth and biochemical versatility, microalgae provide a sustainable route for converting captured carbon into bioenergy and high‐value products ...
Ha‐Neul Choi, Jeong‐Mi Do, Su‐Bin Park, Myeong‐Jun Gwon, Geum‐Sook Do, Ho‐Sung Yoon   +5 more
wiley   +1 more source

Ruthenium Compounds Differentially Inhibit Group IA and IIA Snake Venom Phospholipase A₂ Anticoagulant Activity. [PDF]

Int J Mol Sci
Nielsen VG, Nielsen SA.
europepmc   +1 more source

Appropriateness of the indication of anticoagulant therapy in patients with non-valvular atrial fibrillation [PDF]

, 2012
Baena Di­ez, JM, Espinosa Gonzalez, AB, Gonzalo Voltas, A, Lora Cabral, MA   +3 more
core  

Trends and variation in the use of andexanet alfa for the reversal of direct oral anticoagulants in NHS trusts in England

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Andexanet alfa was recommended by the National Institute for Health and Clinical Excellence (NICE) as an option in the management of life‐threatening gastrointestinal bleeding in patients taking apixaban or rivaroxaban in May 2021. A recent UK‐wide survey of local hospital protocols for the use of andexanet alfa suggested that practice ...
Louis Fisher, Richard Buka, Rosalind Byrne, Stephen Black, Helen J. Curtis, Christopher Wood, Andrew Brown, Sebastian Bacon, Richard Croker, Ben Goldacre, Brian MacKenna, Victoria Speed   +11 more
wiley   +1 more source

Comparative efficacy and safety of anticoagulant, combination, and antiplatelet therapies in patients with intracardiac thrombus: a real-world retrospective study. [PDF]

Front Med (Lausanne)
Jiang C, Wang X, Wang B, Chen X, Xu B, Ni J, Sha D.   +6 more
europepmc   +1 more source

Clinical pharmacology and prescribing education: An updated medical school curriculum from the British Pharmacological Society

British Journal of Clinical Pharmacology, EarlyView.
Aims Prescribing is a complex, essential skill that doctors must acquire to practice medicine safely and effectively. The British Pharmacological Society has historically provided a core curriculum to guide clinical pharmacology and prescribing education in UK medical schools.
Dagan O. Lonsdale, Clare Guilding, Jennifer Koenig, Michael Okorie, Reecha Sofat, Simon Maxwell   +5 more
wiley   +1 more source

Intravenous lanadelumab for the treatment of moderately ill COVID‐19 patients

British Journal of Clinical Pharmacology, EarlyView.
Aims Kallikrein‐kinin system (KKS) dysregulation is hypothesized to play a pathogenetic role in COVID‐19‐associated pulmonary oedema. To investigate the efficacy and safety of intravenous lanadelumab, a monoclonal antibody that inhibits plasma kallikrein, in COVID‐19, we conducted a phase 2, open‐label, randomized‐controlled, proof‐of‐concept ...
Job J. Engel, Christine van Linge, W. Joost Wiersinga, Ilse J. E. Kouijzer, Quirijn de Mast, Robert‐Jan Hassing, Danique J. H. Huijbens, Helen L. Leavis, Roger Schutgens, Coen Maas, Kit C. B. Roes, Frank L. van de Veerdonk, Roger Brüggemann   +12 more
wiley   +1 more source

Timing of DOAC Initiation After Atrial Fibrillation-Related Acute Ischemic Stroke: A Unified Protocol Harmonizing Clinical Safety and Imaging-Based Precision in the Post-CATALYST Era. [PDF]

Cureus
Mojumder D, Popat A.
europepmc   +1 more source